{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:02:47Z","timestamp":1787169767825,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"\n Background:<\/jats:title>\n Preeclampsia poses a significant risk of maternal and neonatal morbidity and mortality. Magnesium sulfate superiority for seizure prophylaxis in severe preeclampsia has been proven globally. However, the search for the lowest effective dose is an area of continuing research.<\/jats:p>\n <\/jats:sec>\n \n Aim:<\/jats:title>\n The aim of this study was to compare the effectiveness of loading dose with the Pritchard regimen of magnesium sulfate for seizure prophylaxis in severe preeclampsia.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n A total of 138 eligible women after 28-week gestation with severe preeclampsia were randomized to either receiving a single loading dose of MgSO\n 4<\/jats:sub>\n (study arm:\n n<\/jats:italic>\n = 69) or Pritchard regimen of MgSO\n 4<\/jats:sub>\n (control:\n n<\/jats:italic>\n = 69). The effectiveness was assessed by the development of seizure. The results obtained were analyzed using SPSS version 21. Categorical variables were analyzed using the Chi-square test and normally distributed continuous variables were analyzed with\n t<\/jats:italic>\n -test and Fisher's exact test.\n P<\/jats:italic>\n < 0.05 was considered statistical significance.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n There were no significant differences between those who received only the loading dose when compared with those who had Pritchard regimen other than a single recorded convulsion among the control group (\n P<\/jats:italic>\n = 0.316). Similarly, except for the duration of hospital stay which was significantly longer in the Pritchard group (\n P<\/jats:italic>\n = 0.019), both the arms of the study shared similar maternal and fetal outcomes.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n This study suggests the effectiveness of just the loading dose of magnesium sulfate when compared with the standardized Pritchard regimen in the prevention of seizure among women with severe preeclampsia. The study also demonstrated safety and similarity in fetal-maternal outcome. The loading dose only had an added advantage of shorter duration of hospital stay.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/aam.aam_111_21","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T08:01:09Z","timestamp":1680508869000},"page":"153-159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A Randomized Controlled Trial of Loading dose Alone Versus Pritchard Regimen of Magnesium Sulphate, for Seizure Prophylaxis in Severe Preeclampsia"],"prefix":"10.4103","volume":"22","author":[{"given":"Anthony Adinoyi","family":"Obanimoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliyu Yabagi","family":"Isah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habiba Ibrahim","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel Daniel","family":"Adewole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bissalah Ahmed","family":"Ekele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-4-20240831","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"R5-4-20240831","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"key":"R6-4-20240831","doi-asserted-by":"crossref","first-page":"269.e1","DOI":"10.1016\/j.ajog.2009.06.060","article-title":"Health of children born to mothers who had preeclampsia: A population-based cohort study","volume":"201","author":"Wu","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R7-4-20240831","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: A WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"R9-4-20240831","first-page":"59","article-title":"Single loading dose of magnesium sulphate in severe preeclampsia and eclampsia-is it effective? A randomized prospective study","volume":"2","author":"Dasgupta","year":"2015","journal-title":"Obstet Gynaecol Int J"},{"key":"R12-4-20240831","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/1471-0528.13753","article-title":"Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia","volume":"123","author":"Okusanya","year":"2016","journal-title":"BJOG"},{"key":"R13-4-20240831","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajog.2017.06.011","article-title":"Health and economic burden of preeclampsia: No time for complacency","volume":"217","author":"Li","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R14-4-20240831","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R15-4-20240831","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2393-13-195","article-title":"Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: A systematic review","volume":"13","author":"Bain","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"R16-4-20240831","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1756-0500-2-165","article-title":"Magnesium sulphate therapy in eclampsia: The Sokoto (ultra short) regimen","volume":"2","author":"Ekele","year":"2009","journal-title":"BMC Res Notes"},{"key":"R17-4-20240831","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.18203\/2320-1770.ijrcog20163870","article-title":"Comparison of low dose Dhaka regimen of magnesium sulphate with standard Pritchard regimen in eclampsia","volume":"5","author":"Sharma","year":"2016","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"R18-4-20240831","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/1471-0528.14400","article-title":"Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: A multi-country survey","volume":"124","author":"Long","year":"2017","journal-title":"BJOG"},{"key":"R19-4-20240831","first-page":"2250","article-title":"Prophylactic magnesium sulphate in severe preeclampsia- Loading dose only versus conventional 24-hour therapy of modified Pritchard's regime-A randomised trial","volume":"4","author":"Ranganna","year":"2014","journal-title":"IOSR J Pharm"},{"key":"R20-4-20240831","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.18203\/2320-1770.ijrcog20162106","article-title":"Use of single-dose prophylactic magnesium sulphate in severe preeclampsia in preventing seizures","volume":"5","author":"Bembalgi","year":"2016","journal-title":"Int J Reprod Contracep Obstet Gynaecol"},{"key":"R21-4-20240831","first-page":"30","article-title":"Loading dose of magnesium sulphate versus standard regime for prophylaxis of pre-eclampsia","volume":"19","author":"Shoaib","year":"2009","journal-title":"J Coll Physicians Surg Pak"},{"key":"R22-4-20240831","first-page":"43","article-title":"University of Abuja teaching hospital in perspectives","volume":"2","author":"Omagbon","year":"2011","journal-title":"UATH Magzine"},{"key":"R23-4-20240831","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0253-7176.116232","article-title":"How to calculate sample size for different study designs in medical research?","volume":"35","author":"Charan","year":"2013","journal-title":"Indian J Psychol Med"},{"key":"R24-4-20240831","doi-asserted-by":"crossref","first-page":"388","DOI":"10.31729\/jnma.3431","article-title":"Loading dose only versus standard dose magnesium sulfate seizure prophylaxis in severe pre-eclamptic women","volume":"56","author":"Rimal","year":"2017","journal-title":"JNMA J Nepal Med Assoc"},{"key":"R25-4-20240831","first-page":"1","article-title":"Single loading dose versus standard 24-hour magnesium sulphate in women with severe preeclampsia and eclampsia: A systematic review and meta-analysis","volume":"42","author":"Salvador","year":"2018","journal-title":"PJOG"},{"key":"R26-4-20240831","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2307\/3583167","article-title":"Is serum magnesium estimate necessary in patients with eclampsia on magnesium sulphate?","volume":"9","author":"Ekele","year":"2005","journal-title":"Afr J Reprod Health"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_111_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:05Z","timestamp":1787166785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_111_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_111_21","relation":{},"ISSN":["1596-3519"],"issn-type":[{"value":"1596-3519","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}